Exercise modulation of BDNF/TrkB signaling in Parkinson’s disease: an evidence-calibrated review of neuroprotective mechanisms, biomarker limitations, and translational gaps - Report - MDSpire

Exercise modulation of BDNF/TrkB signaling in Parkinson’s disease: an evidence-calibrated review of neuroprotective mechanisms, biomarker limitations, and translational gaps

  • By

  • Chuan Chen

  • Kaihua Liu

  • Meng Xiang

  • Xueqin Zhang

  • June 25, 2026

  • 0 min

Share

Clinical Report: Modulation of BDNF/TrkB Pathways through Exercise in Parkinson’s Disease

Overview

This review discusses the role of exercise in modulating BDNF/TrkB signaling pathways in Parkinson's disease (PD) and identifies key translational gaps in current research, particularly regarding biomarker limitations and the need for tailored exercise prescriptions.

Background

Parkinson's disease is a progressive neurodegenerative disorder marked by dopaminergic neuronal loss, leading to significant motor and non-motor impairments. Current pharmacological treatments do not halt disease progression, prompting interest in adjunctive strategies like exercise. Understanding the biological mechanisms through which exercise impacts PD is crucial for developing effective interventions.

Data Highlights

No numerical data or trial results were provided in the source material.

Key Findings

  • BDNF and TrkB signaling pathways are implicated in neuronal survival and synaptic plasticity in the context of PD.
  • Animal studies suggest that exercise activates the PI3K/Akt and MAPK/ERK pathways, contributing to dopaminergic preservation.
  • There are significant translational gaps, including limitations in peripheral BDNF biomarkers and discrepancies between human studies and animal models.
  • Specific exercise prescriptions should align with BDNF/TrkB-related mechanisms.

Clinical Implications

Consideration of structured exercise as a complementary approach in managing Parkinson's disease may be warranted, given its potential to influence biological pathways.

Conclusion

Further research is needed to bridge existing translational gaps in understanding the modulation of BDNF/TrkB pathways through exercise in Parkinson's disease.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. NG71 Parkinsons disease: Full guideline, NICE, 2024 -- Full guideline
  6. Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease, JAMA Neurology, 2017 -- Phase 2 Randomized Clinical Trial
  7. Effects and Mechanisms of Exercise on Brain-Derived Neurotrophic Factor (BDNF) Levels and Clinical Outcomes in People with Parkinson’s Disease, PMC -- Systematic Review and Meta-Analysis
  8. NG71 Parkinsons disease: Full guideline
  9. Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial | Neurology | JAMA Neurology | JAMA Network
  10. Effects and Mechanisms of Exercise on Brain-Derived Neurotrophic Factor (BDNF) Levels and Clinical Outcomes in People with Parkinson’s Disease: A Systematic Review and Meta-Analysis - PMC

Original Source(s)

Related Content